Research

Evidence supporting the use of medical cannabis

Research Studies Worldwide

For over 40 years, scientists and clinicians all over the world have studied the therapeutic efficacy of cannabis, its extracts, and refined phytochemicals. This research is accompanied by a vast amount of anecdotal evidence and case reports of therapeutic benefit.

400 Studies worldwide, including:
245 United States
45 Europe
32 Canada
25 Israel
4 Latin America
3 Australia
*Source: US National Library of Medicine. Last updated June 2018.

Current State of Evidence

Chronic pain in adults

“There is substantial evidence that cannabis is an effective treatment for chronic pain in adults.”

 

 

Chemotherapy-induced nausea and vomiting

“There is conclusive evidence that oral cannabinoids are effective antiemetics in the treatment of chemotherapy‑induced nausea and vomiting.”

Muscle spasticity in multiple sclerosis (MS)

“There is substantial evidence that oral cannabinoids are an effective treatment for improving patient-reported multiple sclerosis spasticity symptoms.”

* Source: National Academies of Sciences, Engineering, and Medicine (2017)

Research at Spectrum Therapeutics

Spectrum Therapeutics is a biopharmaceutical company that develops innovative cannabis-based products to create a range of effective formulations and delivery mechanisms and research their therapeutic effects.

 

We aim to leverage this R&D to improve the quality of life and health of those suffering from acute and chronic illnesses worldwide.

Spectrum Therapeutics has filed 8 provisional US patents relating to studies in:
 
  • Fibromyalgia
  • Amyotrophic Lateral Sclerosis (also known as ALS or Lou Gehrig's disease)
  • Anxiety and its various sub-groups (in humans and animals, in conjunction with  Canopy Animal Health)
  • Cognitive enhancement (in humans and animals, in conjunction with Canopy Animal Health)
  • Pain and various sub-groups (in humans and animals, in conjunction with Canopy Animal Health)
  • Opioid sparing, pain management, and addiction (through Beckley Canopy Therapeutics)

Research Applications

Through our research programs, we aim to create natural plant-based medicines and health products derived from cannabis to improve the quality of life for those affected by acute and chronic illness. We support applicants who are rigorous with their research and committed to advancing cannabinoid science.

 

Due to the large number of research requests that we have received, we regret that we are not accepting new research requests at this time. Please check back with us for future research requests.

This website uses cookies to recognize your computer or device to give you the best user experience and to improve its features. You can disable cookies through your browser but some features of the site will no longer be available. To read our Website Privacy Statement, click here.